Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...
An international research team has identified a human protein, ANKLE1, as the first DNA-cutting enzyme (nuclease) in mammals ...
Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...
By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...
That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of liver conditions ranging from simple ...
Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...
RFdiffusion2, RFdiffusion3, and Riff-Diff each solve different structural problems in computational enzyme design ...
Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...
MedPage Today on MSN
For Your Patients: What to Know About the Newest Treatments for HR+/HER2- Breast Cancer
The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback